COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,233 Articles (22,733 medRxiv, 8,500 bioRxiv)

Most recent first Previous |  Page 1980: Articles 19791-19800  | Next

The seroprevalence and trends of SARS-CoV-2 in Delhi, India: A repeated population-based seroepidemiological study
Sharma, N., Sharma, P., Basu, S., Saxena, S., Chawla, R., Dushyant, K., Mundeja, N., Marak, Z. S., Singh, S., Singh, G. K., Rustagi, R.
10.1101/2020.12.13.20248123 — Posted: 2020-12-14
Self-harm presentations to Emergency Departments and Place of Safety during the first wave of the UK COVID-19 pandemic: South London and Maudsley data on service use from February to June 2020.
Nuzum, E., Martin, E., Morgan, G., Dutta, R., Mueller, C., Polling, C., Pritchard, M., Velupillai, S., Stewart, R.
10.1101/2020.12.10.20247155 — Posted: 2020-12-14
Treatment provision for adults with ADHD during the COVID-19 pandemic: An exploratory study on patient and therapist experience with on-site sessions using face masks vs. telepsychiatric sessions
Wyler, H., Liebrenz, M., Ajdacic-Gross, V., Seifritz, E., Young, S., Burger, P., Buadze, A.
10.1101/2020.12.11.20242511 — Posted: 2020-12-14
Changes in cardiovascular disease monitoring in English primary care during the COVID-19 pandemic: an observational cohort study
Bankhead, C. R., Lay-Flurrie, S., Nicholson, B. D., Sheppard, J. P., Gale, C. P., Liyanage, H., McGagh, D., Minchin, M., Perera, R., Sherlock, J., Smith, M., Thomas, N. P., Wright Drakesmith, C., de Lusignan, S. D., Hobbs, R.
10.1101/2020.12.11.20247742 — Posted: 2020-12-14
Current forecast of COVID-19: a Bayesian and Machine Learning approaches
Prieto, K.
10.1101/2020.12.11.20231829 — Posted: 2020-12-14
Social Media Study of Public Opinions on Potential COVID-19 Vaccines: Informing Dissent, Disparities, and Dissemination
Lyu, H., Wang, J., Wu, W., Duong, V., Zhang, X., Dye, T. D., Luo, J.
10.1101/2020.12.12.20248070 — Posted: 2020-12-14
Azithromycin in Hospitalised Patients with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby, P. W., Roddick, A., Spata, E., Staplin, N., Emberson, J. R., Pessoa-Amorim, G., Peto, L., Campbell, M., Brightling, C., Prudon, B., Chadwick, D., Ustianowski, A., Ashish, A., Todd, S., Yates, B., Buttery, R., Scott, S., Maseda, D., Baillie, J. K., Buch, M. H., Chappell, L. C., Day, J. N., Faust, S. N., Jaki, T., Jeffery, K., Juszczak, E., Lim, W. S., Montgomery, A., Mumford, A., Rowan, K., Thwaites, G., Mafham, M., Haynes, R., Landray, M. J.
10.1101/2020.12.10.20245944 — Posted: 2020-12-14
Impact of mass testing during an epidemic rebound of SARS-CoV-2: A modelling study
Bosetti, P., Tran Kiem, C., Yazdanpanah, Y., Fontanet, A., Lina, B., Colizza, V., Cauchemez, S.
10.1101/2020.12.08.20246009 — Posted: 2020-12-13
Identification of four linear B-cell epitopes on the SARS-CoV-2 spike protein able to elicit neutralizing antibodies
Li, L., Zhao, Z., Yang, X., Li, W., Chen, S., Sun, T., Wang, L., He, Y., Liu, G., Han, X., Wen, H., Liu, Y., Chen, Y., Wang, H., Li, J., Su, Z., Chen, D., Wang, Y., Li, X., Yang, Z., Wang, J., Li, M., Wang, T., Wang, Y., Fan, Y., Wang, H., Zhang, J.
10.1101/2020.12.13.422550 — Posted: 2020-12-13
SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome
Zhang, L., Richards, A., Khalil, A., Wogram, E., Ma, H., Young, R. A., Jaenisch, R.
10.1101/2020.12.12.422516 — Posted: 2020-12-13 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).